Serial Transplantation of Adult T Cell Leukemia Cells into Severe Combined Immunodeficient Mice
- 1 September 1996
- journal article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 87 (9) , 887-892
- https://doi.org/10.1111/j.1349-7006.1996.tb02116.x
Abstract
The precise mechanism of the neoplastic cell growth of adult T cell leukemia (ATL) still remains unclear. In the present study, we have succeeded in serial transplantation of ATL cells from a patient into severe combined immunodeficient (SCID) mice. In this model, we found that only a leukemic cell clone from an ATL patient could be successively transplanted into SCID mice, although it was difficult to maintain leukemic cell clones in vitro, suggesting that the microenvironment provided by SCID mice is suitable for leukemic cell growth. We could not detect human T cell leukemia virus type I (HTLV‐I) mRNA or interleukin 2 (IL‐2) mRNA in either the tumor cells growing in mice or the original leukemic cells. Thus, it appears that neither HTLV‐I viral expression nor the IL‐2 autocrine mechanism is directly involved in the neoplastic cell growth of fresh ATL cells as well as HTLV‐I‐infected cell lines, at least in SCID mice. In addition, we could passage frozen cells and obtain a large number of expanded leukemic cells in this model. Such a serial transplantation model, which can avoid the changes in the nature of leukemic cells that are frequently observed in in vitro culture, and which can propagate leukemic cell clones, would be very suitable not only to study the mechanism of neoplastic cell growth, but also to test potential therapeutic agents for ATL.Keywords
This publication has 31 references indexed in Scilit:
- Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor beta chain monoclonal antibody in mice.The Journal of Experimental Medicine, 1993
- Pseudo-high affinity interleukin 2 (IL-2) receptor lacks the third component that is essential for functional IL-2 binding and signaling.The Journal of Experimental Medicine, 1992
- c-fos promoter trans-activation by the tax1 protein of human T-cell leukemia virus type I.Proceedings of the National Academy of Sciences, 1988
- Close association between interleukin 2 receptor mRNA expression and human T cell leukemia/lymphoma virus type I viral RNA expression in short-term cultured leukemic cells from adult T cell leukemia patients.Journal of Clinical Investigation, 1988
- Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type I.Proceedings of the National Academy of Sciences, 1987
- Expression of a Provirus of Human T Cell leukaemia Virus Type I by DNA TransfectionJournal of General Virology, 1987
- Origin of human T-lymphotrophic virus I-positive T cell lines in adult T cell leukemia. Analysis of T cell receptor gene rearrangement.The Journal of Experimental Medicine, 1985
- The pX Protein of HTLV-I Is a Transcriptional Activator of Its Long Terminal RepeatsScience, 1985
- A Transcriptional Activator Protein Encoded by the x- lor Region of the Human T-Cell Leukemia VirusScience, 1985
- Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphomaProceedings of the National Academy of Sciences, 1980